Daniel Wagner
Impact in
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Urinary Tract Infections Management 2
-
- Pharmacogenetics and Drug Metabolism 2
- Antibiotics Pharmacokinetics and Efficacy 2
- Co-authors
- Peter Langguth (4 shared papers)H. Spahn‐Langguth (2 shared papers)W.P. Jones (2 shared papers)E. H. Flewellen (2 shared papers)Abeer Hanafy (1 shared paper)John Conklin (4 shared papers)Michael B. Bolger (1 shared paper)R. Wanitschke (1 shared paper)
- Journals
- International Journal of Pharmaceutics (2 papers)British Journal of Pharmacology (2 papers)Medicine & Science in Sports & Exercise (1 paper)Strahlentherapie und Onkologie (1 paper)Advanced Drug Delivery Reviews (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Daniel Wagner
15 papers receiving 322 citations
Peers
Comparison fields: 5 of 68
- Pharmaceutical Science 90
- Pharmacology 49
- Oncology 90
- Anesthesiology and Pain Medicine 15
- Cardiology and Cardiovascular Medicine 48
Countries citing papers authored by Daniel Wagner
This map shows the geographic impact of Daniel Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Wagner more than expected).
Fields of papers citing papers by Daniel Wagner
This network shows the impact of papers produced by Daniel Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Wagner. The network helps show where Daniel Wagner may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Wagner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1983 | 109 | |
| 2 | 2001 | 90 | |
| 3 | 2006 | 49 | |
| 4 | 2006 | 18 | |
| 5 | 2003 | 13 | |
| 6 | 1969 | 12 | |
| 7 | 1971 | 9 | |
| 8 | 2024 | 7 | |
| 9 | 1973 | 7 | |
| 10 | 2013 | 5 | |
| 11 | [Intestinal absorption of insulin with a new telemetric shuttle in dogs]. | 1991 | 4 |
| 12 | 1995 | 4 | |
| 13 | 1989 | 3 | |
| 14 | 2014 | 2 | |
| 15 | 1984 | 2 | |
| 16 | 2022 | 0 |
About Daniel Wagner
Daniel Wagner is a scholar working on Epidemiology, Pharmacology, Pharmacology, Pediatrics, Perinatology and Child Health and Pharmaceutical Science, having authored 16 papers that have together received 334 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (2 papers), Drug Solubulity and Delivery Systems (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Analytical Methods in Pharmaceuticals (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Urinary Tract Infections Management (2 papers), Diet and metabolism studies (1 paper) and Advanced Radiotherapy Techniques (1 paper). The work is most often cited by research in Pharmaceutical Science (90 citations), Pharmacology (49 citations), Oncology (90 citations), Anesthesiology and Pain Medicine (15 citations) and Cardiology and Cardiovascular Medicine (48 citations). Daniel Wagner has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Peter Langguth, H. Spahn‐Langguth, W.P. Jones, E. H. Flewellen, Abeer Hanafy, John Conklin, Michael B. Bolger, R. Wanitschke, Hildegard Spahn‐Langguth and Wolfgang Tremel. Their work appears in journals such as International Journal of Pharmaceutics, British Journal of Pharmacology, Medicine & Science in Sports & Exercise, Strahlentherapie und Onkologie and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.